CN Patent

CN1819817A — 一种泰克利玛的固体分散体

Assigned to Chong Kun Dang Corp · Expires 2006-08-16 · 20y expired

What this patent protects

本发明是关于一种泰克利玛的固体分散体的载体，该载体通过使用亲水亲油平衡(HLB)值高于或等于约7的固体表面活性剂制备。所述表面活性剂同时具备载体和分散增强剂的作用。因此，泰克利玛的分散率得到改善，并且口服吸收性和生物利用度可以因快速的药物释放而增加。

USPTO Abstract

本发明是关于一种泰克利玛的固体分散体的载体，该载体通过使用亲水亲油平衡(HLB)值高于或等于约7的固体表面活性剂制备。所述表面活性剂同时具备载体和分散增强剂的作用。因此，泰克利玛的分散率得到改善，并且口服吸收性和生物利用度可以因快速的药物释放而增加。

Drugs covered by this patent

Prograf (TACROLIMUS) · Astellas Pharma

Patent Metadata

Patent number: CN1819817A
Jurisdiction: CN
Classification: —
Expires: 2006-08-16
Drug substance claim: No
Drug product claim: No
Assignee: Chong Kun Dang Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.